1. Home
  2. MTEX vs SNGX Comparison

MTEX vs SNGX Comparison

Compare MTEX & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

N/A

Current Price

$7.04

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTEX
SNGX
Founded
1993
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
8.2M
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
MTEX
SNGX
Price
$7.04
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
53.3K
★ 200.0K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.03
EPS
★ 1.02
N/A
Revenue
★ $108,038,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.55
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.80
$0.28
52 Week High
$12.45
$1.97

Technical Indicators

Market Signals
Indicator
MTEX
SNGX
Relative Strength Index (RSI) 50.60 40.65
Support Level $6.94 $0.35
Resistance Level $8.03 $0.41
Average True Range (ATR) 0.61 0.01
MACD -0.15 -0.00
Stochastic Oscillator 47.64 14.44

Price Performance

Historical Comparison
MTEX
SNGX

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: